Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Inhale/Centeon agreement for alpha1-proteinase inhibitor

Jan. 15, 1997

FDA proposes withdrawal of terfenadine products

Jan. 15, 1997

New PDE IV/TNF inhibitors from Chiroscience

Jan. 15, 1997

PDE IV inhibitors revealed by Byk Gulden

Jan. 15, 1997

Ventus progressing well in phase III

Jan. 13, 1997

Bio-Technology General's OxSODrol tested for safety and efficacy

Jan. 13, 1997

French investigators announce success of gene therapy for CF

Jan. 13, 1997

Dual TNF/PDE IV inhibitors described by Chiroscience

Jan. 13, 1997

RPR seeks FDA approval for Nasacort-HFA

Jan. 10, 1997

SciClone cystic fibrosis drug cleared for clinical testing

Jan. 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 11, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 11, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
US lawmakers demand that Kennedy be held accountable
BioWorld
As the systematic dismantling of the U.S. vaccine schedule escalates, the demands to hold Health and Human Services Secretary Robert Kennedy accountable are...
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...